Zobrazeno 1 - 10
of 3 345
pro vyhledávání: '"Scarlett, J."'
Autor:
Huang, Daniel Q., Ahlholm, Noora, Luukkonen, Panu K., Porthan, Kimmo, Amangurbanova, Maral, Madamba, Egbert, Bettencourt, Richele, Siddiqi, Harris, Cervantes, Vanessa, Hernandez, Christie, Lopez, Scarlett J., Richards, Lisa, Nemes, Katriina, Isoniemi, Helena, Yki-Järvinen, Hannele, Loomba, Rohit
Publikováno v:
In Clinical Gastroenterology and Hepatology January 2024 22(1):81-90
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Adam R. Aluisio, Scarlett J. Bergam, Janet Sugut, John Kinuthia, Rose Bosire, Eric Ochola, Beatrice Ngila, Kate M. Guthrie, Tao Liu, Mary Mugambi, David A. Katz, Carey Farquhar, Michael J. Mello
Publikováno v:
Global Health Action, Vol 16, Iss 1 (2023)
Background Emergency department-based HIV self-testing (ED-HIVST) could increase HIV-testing services to high-risk, under-reached populations. Objectives This study sought to understand the injury patient acceptability of ED-HIVST. Methods Injury pat
Externí odkaz:
https://doaj.org/article/56be20ac16b648328dae39096b78c2f6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aluisio, Adam R.1 (AUTHOR) adam_aluisio@brown.edu, Bergam, Scarlett J.1 (AUTHOR), Sugut, Janet2 (AUTHOR), Kinuthia, John3 (AUTHOR), Bosire, Rose4 (AUTHOR), Ochola, Eric3 (AUTHOR), Ngila, Beatrice3 (AUTHOR), Guthrie, Kate M.5 (AUTHOR), Liu, Tao6 (AUTHOR), Mugambi, Mary7 (AUTHOR), Katz, David A.8 (AUTHOR), Farquhar, Carey8,9,10 (AUTHOR), Mello, Michael J.1 (AUTHOR)
Publikováno v:
Global Health Action. 2023, Vol. 16 Issue 1, p1-9. 9p.
Autor:
Nobuharu Tamaki, Noora Ahlholm, Panu K. Luukkonen, Kimmo Porthan, Suzanne R. Sharpton, Veeral Ajmera, Yuko Kono, Shravan Dave, Aijaz Ahmed, Vinay Sundaram, Michael J. Wilkinson, Heather Patton, Hersh Gupta, Vanessa Cervantes, Christie Hernandez, Scarlett J. Lopez, Ria Loomba, Amanda Baumgartner, Lisa Richards, Perttu E.T. Arkkila, Katriina Nemes, Helena Isoniemi, Hannele Yki-Järvinen, Rohit Loomba
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 21 (2022)
BACKGROUND A pilot, single-center study showed that first-degree relatives of probands with nonalcoholic fatty liver disease (NAFLD) cirrhosis have a high risk of advanced fibrosis. We aimed to validate these findings using 2 independent cohorts from
Externí odkaz:
https://doaj.org/article/77b42bd5d0e9458fb164e2eea0f8a88b
Autor:
Ledder O; Juliet Keidan Institute of Paediatric Gastroenterology, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Dolinger M; Division of Pediatric Gastroenterology, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dubinsky MC; Division of Pediatric Gastroenterology, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Stein R; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, PA, USA., Vellanki S; Division of Pediatric Gastroenterology, Hepatology and Nutrition, UT Southwestern Medical Center and Children's Medical Center, Dallas, TX, USA., Buckuk R; Juliet Keidan Institute of Paediatric Gastroenterology, Shaare Zedek Medical Center, Jerusalem, Israel., Fatima A; Pediatric IBD Center, Beaumont Children's Hospital, Royal Oak, MI, USA., Suskind DL; Division of Gastroenterology, Seattle Children's Hospital Inflammatory Bowel Disease Center, Seattle, WA, USA., Scarlett J; Division of Gastroenterology, Seattle Children's Hospital Inflammatory Bowel Disease Center, Seattle, WA, USA., Röser D; Pediatric Department, Copenhagen University Hospital, Hvidovre, Denmark., Shouval DS; Institute of Gastroenterology Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petach Tikva.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Meyer G; Division of Pediatric Gastroenterology, Nemours Children's Hospital, Wilmington, DE, USA., Rios ZM; Division of Pediatric Gastroenterology, Nemours Children's Hospital, Wilmington, DE, USA., Pujol-Muncunill G; Pediatric Gastroenterology, Hepatology and Nutrition Department, Hospital Sant Joan de Deu, Barcelona, Spain., Lozano A; Pediatric Gastroenterology, Hepatology and Nutrition Department, Hospital Sant Joan de Deu, Barcelona, Spain., Kolho KL; Pediatric Gastroenterology Department, Children's Hospital HUS, Helsinki University, Helsinki, Finland., Rohani P; Pediatric Gastroenterology and Hepatology Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran., Hussey S; Department of Paediatric Gastroenterology, Children's Health Ireland, Royal College of Surgeons of Ireland and University College Dublin, Dublin, Ireland., de Mejj T; Department of Pediatric Gastroenterology, AG&M Research Institute, Amsterdam UMC, Amsterdam, the Netherlands., Ayers T; Division of Pediatric Gastroenterology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Navas-López VM; Pediatric Gastroenterology and Nutrition Unit, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Málaga, Spain., Turner D; Juliet Keidan Institute of Paediatric Gastroenterology, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Tzivinikos C; Paediatric Gastroenterology Department, Al Jalila Children's Specialty Hospital, Mohammed Bin Rashid University, Dubai, United Arab Emirates.
Publikováno v:
Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jun 03. Date of Electronic Publication: 2024 Jun 03.
Autor:
Babarczy B; Unit of Knowledge Management, Evidence and Research for Policy-Making, Division of Information, Evidence, Research and Innovation, World Health Organization Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Denmark.; Syreon Research Institute, Budapest, Hungary., Scarlett J; Unit of Knowledge Management, Evidence and Research for Policy-Making, Division of Information, Evidence, Research and Innovation, World Health Organization Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Denmark., Sharma T; Unit of Knowledge Management, Evidence and Research for Policy-Making, Division of Information, Evidence, Research and Innovation, World Health Organization Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Denmark.; Evidence to Policy, Gyvelvej, Hoersholm, Denmark., Gaál P; Health Services Management Training Centre, Semmelweis University Health Services Management Training Centre, Kútvölgyi Út 2, Budapest, 1125, Hungary. gaal.peter@emk.semmelweis.hu., Szécsényi-Nagy B; Health Services Management Training Centre, Semmelweis University Health Services Management Training Centre, Kútvölgyi Út 2, Budapest, 1125, Hungary., Kuchenmüller T; Unit of Knowledge Management, Evidence and Research for Policy-Making, Division of Information, Evidence, Research and Innovation, World Health Organization Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Denmark.
Publikováno v:
Health research policy and systems [Health Res Policy Syst] 2024 Apr 20; Vol. 22 (1), pp. 50. Date of Electronic Publication: 2024 Apr 20.
Autor:
Scarlett J Barker, Mai B Thayer, Chaeyoung Kim, David Tatarakis, Matthew Simon, Rebekah L Dial, Lizanne Nilewski, Robert C Wells, Yinhan Zhou, Megan Afetian, Alfred Chappell, Kylie S Chew, Johann Chow, Allisa Clemens, Claire B Discenza, Jason Dugas, Chrissa Dwyer, Timothy Earr, Connie Ha, David Huynh, Srini Jayaraman, Wanda Kwan, Cathal Mahon, Michelle Pizzo, Elysia Roche, Laura Sanders, Alexander Stergioulis, Raymond Tong, Hai Tran, Joy Zuchero, Anthony A Estrada, Kapil Gadkar, Christopher MM Koth, Pascal E Sanchez, Robert G Thorne, Ryan J Watts, Thomas Sandmann, Lesley Kane, Frank Rigo, Mark S Dennis, Joseph W Lewcock, Sarah L DeVos
Antisense oligonucleotides (ASO) are promising therapies for neurological disorders, though they are unable to cross the blood-brain barrier (BBB) and must be delivered directly to the central nervous system (CNS). Here, we use a human transferrin re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56046f97df89d6a2d15a721b2fca4f31
https://doi.org/10.1101/2023.04.25.538145
https://doi.org/10.1101/2023.04.25.538145
Autor:
Bergam, Scarlett J.
Publikováno v:
Academic Medicine; Jun2024, Vol. 99 Issue 6, pe2-e3, 2p